Antipodes Partners’s Flowserve FLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,305,815
Closed -$53.8M 71
2023
Q4
$53.8M Sell
1,305,815
-379,626
-23% -$14.6M 1.68% 23
2023
Q3
$66.5M Sell
1,685,441
-87,309
-5% -$3.37M 2.14% 20
2023
Q2
$65.9M Sell
1,772,750
-63,884
-3% -$2.22M 2.27% 21
2023
Q1
$62.4M Buy
1,836,634
+206,413
+13% +$6.91M 2.16% 18
2022
Q4
$50M Buy
1,630,221
+534,193
+49% +$15.6M 1.79% 23
2022
Q3
$26.6M Sell
1,096,028
-158,945
-13% -$4.81M 1.07% 32
2022
Q2
$35.9M Sell
1,254,973
-58,330
-4% -$1.86M 1.5% 28
2022
Q1
$47.1M Buy
+1,313,303
New +$42.9M 1.67% 23

Other funds holding FLS

Antipodes Partners's FLS Position: Q1 2024 in Review

Antipodes Partners sold out of Flowserve (FLS) in Q1 2024, closing a stake of 1,305,815 shares — an estimated $53.8M sold.

Antipodes Partners first reported a position in FLS in Q1 2022 and held it in 8 quarters. The position peaked at $66.5M in Q3 2023. 399 funds tracked by Wall St. Rank hold FLS as of Q1 2024.

  • Antipodes Partners reported no remaining Flowserve position as of Q1 2024 after selling out during the quarter.
  • Antipodes Partners sold 1,305,815 Flowserve shares in Q1 2024, an estimated $53.8M.
  • Antipodes Partners first reported a position in Flowserve in Q1 2022 and held it in 8 quarters.
  • Antipodes Partners's Flowserve position peaked at $66.5M in Q3 2023.
  • 399 funds tracked by Wall St. Rank held Flowserve as of Q1 2024.

Based on Antipodes Partners's 13F filing for Q1 2024, filed 7 May 2024.